Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 26/74 ]
NASDAQ | Common Stock
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting.
The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus.
In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings.
Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 31, 26 | -4.09 Decreased by -1.49 K% | -3.75 Decreased by -9.05% |
| Mar 19, 26 | -4.44 Decreased by -1.07 K% | -0.13 Decreased by -3.31 K% |
| Nov 13, 25 | -0.16 Increased by +50.00% | -0.16 |
| Aug 14, 25 | -0.23 Decreased by -64.29% | -0.66 Increased by +65.15% |
| May 7, 25 | -0.26 Increased by +16.97% | -0.33 Increased by +22.00% |
| Mar 12, 25 | -0.38 Increased by +24.44% | -0.34 Decreased by -11.12% |
| Nov 7, 24 | -0.32 Decreased by -60.00% | -0.33 Increased by +3.03% |
| Aug 8, 24 | -0.14 Increased by +54.84% | -0.34 Increased by +58.82% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 145.95 K Increased by +190.30% | -9.14 M Decreased by -21.33% | Decreased by -6.26 K% Increased by +58.21% |
| Dec 31, 25 | 263.92 K Increased by +76.74% | -25.75 M Decreased by -133.39% | Decreased by -9.76 K% Decreased by -32.05% |
| Sep 30, 25 | 145.38 K Decreased by -77.32% | -5.89 M Increased by +39.29% | Decreased by -4.05 K% Decreased by -167.74% |
| Jun 30, 25 | 162.91 K Decreased by -93.87% | -7.73 M Decreased by -1.72% | Decreased by -4.75 K% Decreased by -1.56 K% |
| Mar 31, 25 | 50.28 K Decreased by -80.11% | -7.53 M Increased by +19.10% | Decreased by -14.98 K% Decreased by -306.68% |
| Dec 31, 24 | 149.32 K Decreased by -95.80% | -11.03 M Increased by +24.84% | Decreased by -7.39 K% Decreased by -1.69 K% |
| Sep 30, 24 | 641.14 K Decreased by -73.91% | -9.70 M Decreased by -62.09% | Decreased by -1.51 K% Decreased by -521.19% |
| Jun 30, 24 | 2.66 M Increased by +1.24 K% | -7.60 M Increased by +14.79% | Decreased by -286.03% Increased by +93.66% |